Bingyu Li received his Master's Degree in Clinical Medicine from Tongji University in 2019. He worked as a Clinical Research Physician at the Luoxin Pharmaceutical Institute (2022–2024). In 2025, he moved to the Mount Sinar West/ Morningside in New York City and is training as a pathology resident. His research topics mainly include cancer therapy, target therapy, clinical trials, cardiology, myocardial infarction, and arrhythmia.
Mount Sinai Health System
New York, USA
Pathology
Graduate Student or Post Graduate
Mount Sinai Health System, New York, USA
01 Jul 2025 - present
Research or Laboratory Scientist
Tongji University School of Medicine
01 Jul 2019 - present
Research or Laboratory Scientist
Luoxin Pharmaceutical (Shanghai) Co., Ltd
01 Feb 2022 - 01 Apr 2024
Manager
Sanofi (China) Investment Co., Ltd
01 Feb 2021 - 01 Feb 2022
Undergraduate Student
Tongji University School of Medicine
01 Jul 2017 - 01 Jul 2019